Form 4: Quest Diagnostics SVP, Clinical Solutions, Karthik Kuppusamy, Reports Stock Sale
SEC Form 4
Karthik Kuppusamy, SVP, Clinical Solutions at Quest Diagnostics, reported selling 1,990 shares of common stock at an average price of $153.2612 on August 28, 2024.
Summary
- On August 28, 2024, Karthik Kuppusamy, SVP, Clinical Solutions at Quest Diagnostics, sold 1,990 shares of common stock.
- The sale was executed at a weighted average price of $153.2612 per share.
- Following the transaction, Kuppusamy directly owns 11,459 shares of Quest Diagnostics common stock.
- Kuppusamy also indirectly owns 358 shares through a trust and 1,556 shares through a 401(k) plan.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a stock sale. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This is a routine disclosure of an insider stock transaction. It's common for executives to periodically sell shares for personal financial management.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders, depending on the overall market reaction.
Key Dates
| Date | Description |
|---|---|
| 08/28/2024 | Date of stock sale transaction |
| 08/29/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.